Your browser doesn't support javascript.
loading
Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning-Eudract #: 2007-002420-15.
Hell, Saskia; Jentzsch, Madlen; Franke, Georg-Nikolaus; Jäkel, Nadja; Schulze, Susann; Edelmann, Jeanett; Nenoff, Kolja; Grieb, Nora; Jeremic, Veljko; Cross, Michael; Leiblein, Sabine; Bach, Enrica; Pönisch, Wolfram; Al-Ali, Haifa-Kathrin; Schwind, Sebastian; Platzbecker, Uwe; Lange, Thoralf; Niederwieser, Dietger; Vucinic, Vladan.
Afiliación
  • Hell S; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Jentzsch M; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Franke GN; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Jäkel N; Department of Hematology/Oncology, University Hospital Halle, Halle (Saale), Germany.
  • Schulze S; Krukenberg Cancer Center, University Halle, Halle (Saale), Germany.
  • Edelmann J; Leipzig Medical Center, Institute of Legal Medicine, University Leipzig, Leipzig, Germany.
  • Nenoff K; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Grieb N; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Jeremic V; Department for Operations Research and Statistics, Faculty of Organizational Sciences, University of Belgrade, Belgrade, Serbia.
  • Cross M; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Leiblein S; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Bach E; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Pönisch W; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Al-Ali HK; Krukenberg Cancer Center, University Halle, Halle (Saale), Germany.
  • Schwind S; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Platzbecker U; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Lange T; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Niederwieser D; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany.
  • Vucinic V; Leipzig Medical Center, Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University Leipzig, Leipzig, Germany. vladan.vucinic@medizin.uni-leipzig.de.
Bone Marrow Transplant ; 57(5): 824-826, 2022 05.
Article en En | MEDLINE | ID: mdl-35181744

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Quimerismo Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Quimerismo Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Alemania